Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
MPTP-mouse model constitutes a well-known model of neuroinflammation and mitochondrial failure occurring in Parkinson's disease (PD). Although it has been extensively reported that nitric oxide (NO●) plays a key role in the pathogenesis of PD, the relative roles of nitric oxide synthase isoform...
Main Authors: | Ana López, Francisco Ortiz, Carolina Doerrier, Carmen Venegas, Marisol Fernández-Ortiz, Paula Aranda, María E Díaz-Casado, Beatriz Fernández-Gil, Eliana Barriocanal-Casado, Germaine Escames, Luis C López, Darío Acuña-Castroviejo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5553810?pdf=render |
Similar Items
-
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial diseaseResearch in context
by: Eliana Barriocanal-Casado, et al.
Published: (2019-04-01) -
Melatonin/Nrf2/NLRP3 Connection in Mouse Heart Mitochondria during Aging
by: Marisol Fernández-Ortiz, et al.
Published: (2020-11-01) -
The Impact of Melatonin and NLRP3 Inflammasome on the Expression of microRNAs in Aged Muscle
by: Ramy KA Sayed, et al.
Published: (2021-03-01) -
The Impact of Melatonin Supplementation and NLRP3 Inflammasome Deletion on Age-Accompanied Cardiac Damage
by: Ramy K. A. Sayed, et al.
Published: (2021-08-01) -
Protective Effects of Melatonin on the Skin: Future Perspectives
by: Iryna Rusanova, et al.
Published: (2019-10-01)